According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period.
in clinical microbiology market can be attributed to factors such as
rising incidence of infectious diseases and growing outbreak of
epidemics and increased funding and public-private investments.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367
global clinical microbiology market is segmented by product, disease
area, end user, and region. On the basis of products, the clinical
microbiology market is segmented into instruments, and reagents. The
reagents product segment is expected to grow at the fastest rate during
the forecast period. The high growth of reagents segment is attributed
to the high prevalence of infectious diseases across major markets
(resulting in a growing number of clinical diagnostic procedures),
growing trend of reagent rental agreements along with instrument sales,
and an increasing number of life science researches in the field of
specific reagents for targeted infectious disease diagnosis &
treatment, especially across emerging countries.
instruments product segment is further subsegmented into laboratory
instruments (incubators, gram stainers, autoclave sterilizers, bacterial
colony counters, microbial air samplers, blood culture counters,
microbial culture systems, anaerobic culture systems, petri dish
fillers, and other laboratory instruments) and microbiology analyzers
(molecular diagnostic instruments, advanced microscopes, and mass
spectrometers). The microbiology analyzer segment is expected to grow at
higher CAGR during the forecast period. The growth of this segment is
attributed to factors such as increasing adoption of advanced analyzers
for disease diagnosis by end users and technological advancements in the
field of molecular diagnostic instruments.
product segment is further subsegmented into pathogen-specific kits and
general reagents. The pathogen-specific kits segment is expected to grow
at higher CAGR during the forecast period. The growth of this segment
is attributed to factors such as the flexibility pathogen-specific kits
offer end users to optimize the reaction for better results and
increasing patient preference across major countries for early and
accurate disease diagnosis (including pathogen detection).
On the basis of disease area, the clinical microbiology market is segmented into respiratory diseases, bloodstream infections (BSIs), gastrointestinal (GI) diseases, sexually transmitted diseases (STDs), urinary tract infections (UTIs), periodontal diseases, and other diseases (including cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases, among others). The significant growth potential offered by the respiratory diseases segment is attributed to factors such as the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (including TB, asthma, COPD, and bronchitis) across developing countries, and increasing number of epidemic outbreaks of respiratory infections.
On the basis of
end user, the clinical microbiology market is segmented into hospitals
and diagnostic centers, custom lab service providers, and academic and
research institutes. The custom lab service providers segment is
estimated to witness the highest growth during the forecast period owing
to the continuous outsourcing of drug testing procedures to laboratory
service providers by pharmaceutical companies, procedural benefits
offered by advanced molecular technology-based instruments (such as PCR
and NGS) in drug discovery and researches, increasing number of
microbiology-based clinical trials, and the growing number of custom lab
service providers across major markets.
Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=219135367
Geographically, Asia Pacific market is expected to grow at the highest CAGR from 2018 to 2023. Key factors driving the growth of the market in APAC are the growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence of infectious diseases in the region.